Intravenous delivery of AAV9-GLB1 gene therapy for GM1 gangliosidosis: An interim analysis

被引：0
|
作者：
D'Souza, Precilla [1 ]
Johnston, Jean M. [1 ]
Thurm, Audrey [2 ]
Farmer, Cristan [2 ]
Gross, Amanda L. [3 ]
Acosta, Maria T. [1 ]
Tifft, Cynthia [1 ]
机构：
[1] NHGRI, NIH, Bethesda, MD USA
[2] NIMH, NIH, Bethesda, MD USA
[3] Auburn Univ, Auburn, AL USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2024年 / 141卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2023.107802
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
63
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Attenuation of ganglioside GM1 accumulation in the brain of GM1 gangliosidosis mice by neonatal intravenous gene transfer
    N Takaura
    T Yagi
    M Maeda
    E Nanba
    A Oshima
    Y Suzuki
    T Yamano
    A Tanaka
    Gene Therapy, 2003, 10 : 1487 - 1493
  • [22] Presymptomatic Gene Therapy Cures Feline GM1 Gangliosidosis
    McCurdy, Victoria J.
    Johnson, Aime K.
    Bradbury, Allison M.
    Randle, Ashley N.
    Gray-Edwards, Heather
    Hwang, Misako
    Leroy, Stanley G.
    Cox, Nancy R.
    Sena-Esteves, Miguel
    Martin, Douglas R.
    MOLECULAR THERAPY, 2012, 20 : S12 - S12
  • [23] Treatment of Feline GM1 Gangliosidosis by Cerebrospinal Fluid Delivery of AAV9 or AAVrh10
    Garrett, Courtney
    Gross, Amanda L.
    Gray-Edwards, Heather
    Sena-Esteves, Miguel
    Martin, Douglas R.
    MOLECULAR THERAPY, 2021, 29 (04) : 179 - 180
  • [24] Gene Therapy for GM1 Gangliosidosis Mediated by AAV Vector Carrying BBB-Penetrable Enzyme
    Matsushima, Saki
    Iizuka, Sayoko
    Kinoshita, Masafumi
    Takagi, Haruna
    Iizuka, Shunsuke
    Ohtsuki, Kota
    Imakiire, Atsushi
    Nagashima, Takashi
    Okamoto, Shinichiro
    Higuchi, Takashi
    Shimada, Yohta
    Hioki, Hiroyuki
    Sonoda, Hiroyuki
    Watabe, Ayako M.
    Ohashi, Toya
    Kobayashi, Hiroshi
    MOLECULAR THERAPY, 2023, 31 (04) : 635 - 636
  • [25] AXO-AAV-GM1 for the treatment of GM1 gangliosidosis: Program Overview
    Corcoran, G.
    Korner, P.
    Benoit, J.
    Tifft, C. J.
    Gray-Edwards, H.
    Sena-Esteves, M.
    Martin, D. R.
    HUMAN GENE THERAPY, 2019, 30 (11) : A148 - A149
  • [26] Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient
    Leclerc, Delphine
    Goujon, Louise
    Jaillard, Sylvie
    Nouyou, Benedicte
    Cluzeau, Laurence
    Damaj, Lena
    Dubourg, Christele
    Etcheverry, Amandine
    Levade, Thierry
    Froissart, Roseline
    Dreano, Stephane
    Guillory, Xavier
    Eriksson, Leif A.
    Launay, Erika
    Mouriaux, Frederic
    Belaud-Rotureau, Marc-Antoine
    Odent, Sylvie
    Gilot, David
    CRISPR JOURNAL, 2023, 6 (01): : 17 - 31
  • [27] Base editing of the GLB1 gene is therapeutic in GM1 gangliosidosis patient-derived cells
    Rha, Allisandra K.
    Kan, Shih-Hsin
    Andrade-Heckman, Perla
    Christensen, Chloe L.
    Harb, Jerry F.
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2024, 143 (1-2)
  • [28] Optimization of AAV-Gene Therapy for GM1-Gangliosidosis
    Stoica, Lorelei
    Todeasa, Sophia
    Lata, Jaclyn
    Martin, Douglas
    Sena-Esteves, Miguel
    MOLECULAR THERAPY, 2016, 24 : S149 - S149
  • [29] Developement of an Ex Vivo Gene Therapy for Infantile GM1 Gangliosidosis
    Bucciarelli, Linda
    Fabris, Camilla
    Milazzo, Rita
    Biffi, Alessandra
    Poletti, Valentina
    MOLECULAR THERAPY, 2023, 31 (04) : 38 - 39
  • [30] An engineered β-galactosidase with improved stability and crosscorrection for the potential treatment of GM1 Gangliosidosis via AAV gene therapy
    Reddy, Charu
    Onguka, Ouma
    Artz, Jacob
    Schmitt, Christopher
    Grossman, Adam
    Santosh, Swetha
    Akinkugbe, Oluwayomi
    Wong, Victoria
    Gebretsadik, Kahsay
    Sedighi, Faezeh
    Tang, Jinyan
    Del Greco, Elizabeth
    Lee, Grace S.
    Kruse, Nikki
    Chng, Chinping
    Duan, Da
    Hallows, William C.
    Chen, Joseph C.
    Akeefe, Hassibullah
    Silverman, Adam P.
    Huisman, Gjalt
    MOLECULAR GENETICS AND METABOLISM, 2023, 138 (02) : 109 - 109
12345